WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has appointed John R. Leone, a Partner at Paul Capital Healthcare to its Board of Directors. Mr. Leone replaces Walter Flamenbaum, M.D. who has served on the Board for the past year. A pharmaceutical industry veteran, Mr. Leone will bring important and relevant insights to the Board of Directors as Oscient continues to build the brand for its lead product, ANTARA® (fenofibrate) capsules and grow its business through strategic corporate development activities.
